D.E. Shaw & Co
CDNA icon

D.E. Shaw & Co’s CareDx CDNA Stock Holding History

D.E. Shaw & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-60,000
Closed -$1.51M – 3616
2018
Q4 		$1.51M Buy
60,000
+52,000
+650% +$1.34M ﹤0.01% 2377
2018
Q3 		$231K Buy
+8,000
New +$150K ﹤0.01% 3478

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's CDNA Position: Q2 2026 in Review

D.E. Shaw & Co increased its CareDx (CDNA) stake by 30% in Q2 2026, buying an estimated $5.72M and bringing the position to 1,137,660 shares worth $32.4M. The position accounts for 0.02% of the portfolio, ranked #1003.

D.E. Shaw & Co first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $89M in Q4 2020. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • D.E. Shaw & Co held 1,137,660 shares of CareDx worth $32.4M as of Q2 2026.
  • D.E. Shaw & Co bought 262,752 CareDx shares in Q2 2026, an estimated $5.72M.
  • CareDx made up 0.02% of D.E. Shaw & Co's portfolio in Q2 2026, its #1003 holding.
  • D.E. Shaw & Co first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
  • D.E. Shaw & Co's CareDx position peaked at $89M in Q4 2020.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.